Top Markets
Coin of the day
RetinalGenix Technologies Inc. RetinalGenix Technologies Inc.

RetinalGenix Technologies Inc.

RTGN
Classifica tra le azioni #23316
RetinalGenix Technologies Inc. is a company dedicated to research and... RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Prezzo delle azioni
$4.00
Ultima sincronizzazione: 2026-08-20
Capitalizzazione di mercato
$75.37M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
12.99%
Paese
US
Scambia RetinalGenix Technologies Inc. (RTGN)

Categoria

Storico del rendimento da dividendi per RetinalGenix Technologies Inc. (RTGN)
Il rendimento da dividendi (TTM) di RetinalGenix Technologies Inc. (simbolo azionario: RTGN) al 2026 è: 0
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per RetinalGenix Technologies Inc. (RTGN) da 2026 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
Non abbastanza dati per le date fornite.
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
2.23%
US
1.03%
US
3.69%
IE
0.00%
US
0.00%
DE